Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study

Introduction Home-based self-rehabilitation programmes combined with botulinum toxin injections (BTIs) appear to be a relevant approach to increase the recommended intensive rehabilitation of patients with spasticity following a stroke. The literature highlights a lack of evidence of beneficial effects of this adjuvant therapy to reduce limitations of patients with stroke. The aim of this study is to assess the effects of a 6-month self-rehabilitation programme in adjunction to BTI, in comparison with BTI alone, to reduce limitations of patients with spasticity following a stroke. Methods and analysis 220 chronic patients will participate to this multicentre, prospective, randomised, controlled, assessor blinded study. All patients will benefit from two successive BTI (3 months apart), and patients randomised in the self-rehabilitation group will perform in adjunction 6 months of self-rehabilitation at home. All patients continue their conventional physiotherapy. The main outcome is the primary treatment goal (PTG), which will be determined jointly by the patient and the medical doctor using Goal Attainment Scaling. Impairments and functions, quality of life, mood and fatigue will be assessed. Botulinum toxin will be injected into the relevant muscles according to the PTG. Patients in the self-rehab group will be taught the self-rehabilitation programme involving respectively 10 min of stretching, 10 min of strengthening and 10 min of task-oriented exercises, corresponding to their PTG. Compliance to the self-rehabilitation programme will be monitored. Ethics and dissemination Patients will sign written informed consent. Ethical approval was obtained from ethics committee. The results will be disseminated in a peer-reviewed journal and presented at international congresses. The results will also be disseminated to patients. Trial registration number NCT02944929.

[1]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[2]  T. Deltombe,et al.  Assessment and treatment of spastic equinovarus foot after stroke: Guidance from the Mont-Godinne interdisciplinary group. , 2017, Journal of rehabilitation medicine.

[3]  M. Sudoł,et al.  Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity , 2016, Clinical rehabilitation.

[4]  Gavin Williams,et al.  The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review , 2015, Brain injury.

[5]  V. Weerdesteyn,et al.  Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia. , 2015, Journal of rehabilitation medicine.

[6]  N. Smania,et al.  Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial , 2015, Clinical rehabilitation.

[7]  D. Pradon,et al.  Energy Cost of Obstacle Crossing in Stroke Patients , 2014, American journal of physical medicine & rehabilitation.

[8]  G. Mead,et al.  Interventions for improving upper limb function after stroke. , 2014, The Cochrane database of systematic reviews.

[9]  I. Baguley,et al.  Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke. , 2014, Journal of rehabilitation medicine.

[10]  L. Turner-Stokes,et al.  Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. , 2013, The Cochrane database of systematic reviews.

[11]  L. Turner-Stokes,et al.  Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management , 2013, BMJ Open.

[12]  R. Teasell,et al.  Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. , 2013, Archives of physical medicine and rehabilitation.

[13]  G. Kwakkel,et al.  Effects of circuit training as alternative to usual physiotherapy after stroke: randomised controlled trial , 2012, BMJ : British Medical Journal.

[14]  Steven A Julious,et al.  Sample sizes for trials involving multiple correlated must‐win comparisons , 2012, Pharmaceutical statistics.

[15]  D. Pradon,et al.  A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients. , 2011, Clinical biomechanics.

[16]  S. Carda,et al.  Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients , 2011, Clinical rehabilitation.

[17]  Marco Baccini,et al.  Efficacy of physiotherapy interventions late after stroke: a meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  N. Lannin,et al.  Botulinum toxin assessment, intervention and after‐care for upper limb hypertonicity in adults: international consensus statement , 2010, European journal of neurology.

[19]  D. Weber,et al.  Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxinA and task practice therapy: a single-blind, randomized controlled pilot study. , 2010, Archives of physical medicine and rehabilitation.

[20]  A. Roby-Brami,et al.  Botulinum Toxin to Treat Upper-Limb Spasticity in Hemiparetic Patients: Analysis of Function and Kinematics of Reaching Movements , 2010, Neurorehabilitation and neural repair.

[21]  Chien-Wei Hsu,et al.  Combined Botulinum Toxin Type A With Modified Constraint-Induced Movement Therapy for Chronic Stroke Patients With Upper Extremity Spasticity: A Randomized Controlled Study , 2010, Neurorehabilitation and neural repair.

[22]  P. Langhorne,et al.  Motor recovery after stroke: a systematic review , 2009, The Lancet Neurology.

[23]  C. Detrembleur,et al.  The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait. , 2009, Gait & posture.

[24]  G. Mead,et al.  Effects of Task-Oriented Circuit Class Training on Walking Competency After Stroke: A Systematic Review , 2009, Stroke.

[25]  Jaap H. Buurke,et al.  The Effectiveness of the Bobath Concept in Stroke Rehabilitation: What is the Evidence? , 2009, Stroke.

[26]  C. Detrembleur,et al.  Effect of Simultaneous Botulinum Toxin Injections Into Several Muscles on Impairment, Activity, Participation, and Quality of Life Among Stroke Patients Presenting With a Stiff Knee Gait , 2008, Stroke.

[27]  Joanna J McAdam,et al.  A systematic review of repetitive functional task practice with modelling of resource use, costs and effectiveness. , 2008, Health technology assessment.

[28]  E. Elovic,et al.  Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. , 2008, Archives of physical medicine and rehabilitation.

[29]  M. Barnes.  Upper Motor Neurone Syndrome and Spasticity: An overview of the clinical management of spasticity , 2008 .

[30]  H. Krebs,et al.  Effects of Robot-Assisted Therapy on Upper Limb Recovery After Stroke: A Systematic Review , 2008, Neurorehabilitation and neural repair.

[31]  A. Jahangir,et al.  Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. , 2007, The Medical journal of Malaysia.

[32]  Subashan Perera,et al.  Improvements in Speed-Based Gait Classifications Are Meaningful , 2007, Stroke.

[33]  C. Pozzilli,et al.  Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis , 2007, Clinical rehabilitation.

[34]  L. Turner-Stokes,et al.  Goal attainment for spasticity management using botulinum toxin. , 2006, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[35]  M. Chatel,et al.  La prise en charge des accidents vasculaires cérébraux en France , 2005 .

[36]  G. Nappi,et al.  A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot , 2005, Neurological Sciences.

[37]  E. Elovic,et al.  Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke , 2004, Neurology.

[38]  P. Langhorne,et al.  Can augmented physiotherapy input enhance recovery of mobility after stroke? A randomized controlled trial , 2004, Clinical rehabilitation.

[39]  E. Roth,et al.  Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical , 2004, Circulation.

[40]  Paul McNamee,et al.  Does an early increased-intensity interdisciplinary upper limb therapy programme following acute stroke improve outcome? , 2003, Clinical rehabilitation.

[41]  R. D'Agostino,et al.  The influence of gender and age on disability following ischemic stroke: the Framingham study. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[42]  O. Hardiman,et al.  A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke , 2003, Cerebrovascular Diseases.

[43]  Konrad Jamrozik,et al.  Long-Term Disability After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study, 1989–1990 , 2002, Stroke.

[44]  A. Forster,et al.  Physiotherapy for patients with mobility problems more than 1 year after stroke: a randomised controlled trial , 2002, The Lancet.

[45]  Richard Greenwood,et al.  Evaluating the role of botulinum toxin in the management of focal hypertonia in adults , 2000, Journal of neurology, neurosurgery, and psychiatry.

[46]  B. Bhakta,et al.  Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial , 2000, Journal of neurology, neurosurgery, and psychiatry.

[47]  H. Topka,et al.  Management of spasticity associated pain with botulinum toxin A. , 2000, Journal of pain and symptom management.

[48]  L. Provinciali,et al.  Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. , 2000, American journal of physical medicine & rehabilitation.

[49]  S. Smith,et al.  A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury , 2000, Clinical rehabilitation.

[50]  B. Bioulac,et al.  A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[51]  S. Olney,et al.  Hemiparetic gait following stroke. Part I: Characteristics , 1996 .

[52]  JoAnne K. Gronley,et al.  Classification of walking handicap in the stroke population. , 1995, Stroke.

[53]  S. Olney,et al.  Temporal, kinematic, and kinetic variables related to gait speed in subjects with hemiplegia: a regression approach. , 1994, Physical therapy.

[54]  J Perry,et al.  STIFF‐LEGGED GAIT IN SPASTIC PARESIS A Study of Quadriceps and Hamstrings Muscle Activity , 1991, American journal of physical medicine & rehabilitation.

[55]  Lippincott Williams Wilkins,et al.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. , 1989, Stroke.

[56]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .

[57]  Thomas J. Kiresuk,et al.  Goal attainment scaling: A general method for evaluating comprehensive community mental health programs , 1968, Community Mental Health Journal.

[58]  T. Twitchell.  The restoration of motor function following hemiplegia in man. , 1951, Brain : a journal of neurology.

[59]  D. Pradon,et al.  Effect of rehabilitation and botulinum toxin injection on gait in chronic stroke patients: a randomized controlled study. , 2015, Journal of rehabilitation medicine.

[60]  M. RocheNGeiger.  Improvement in the Gait Pattern of Chronic Stroke Patients following Repetitive Multifocal Botulinum Toxin Injections: An Observational Study , 2014 .

[61]  I. Baguley,et al.  Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. , 2010, Journal of rehabilitation medicine.

[62]  Paolo Manganotti,et al.  European consensus table on the use of botulinum toxin type A in adult spasticity. , 2009, Journal of rehabilitation medicine.

[63]  Didier Pradon,et al.  Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. , 2009, Gait & posture.

[64]  A. Rodriquez,et al.  Botulinum toxin injection of spastic finger flexors in hemiplegic patients. , 2000, American journal of physical medicine & rehabilitation.